Clinical Guest Contributors

  1. 'How Do You Feel?': Designing A Cardiac Trial With A Patient-Reported Primary Endpoint 8/21/2026

    Imbria Pharmaceuticals' Albert Kim, MD, Ph.D., shares why PROs are the point of the company's FORTITUDE-HCM trial for patients with non-obstructive hypertrophic cardiomyopathy.

  2. The Reality Of Clinical Research Federal Funding Cuts 8/20/2026

    Although the most catastrophic federal funding cuts didn't come to fruition, Pamela Garzone discusses where some impacts are being felt now and will be felt for years to come.

  3. Building The Execution Architecture For Real-World Data To Have Real-World Impact 8/20/2026

    RWE's next challenge is execution. Learn how life sciences orgns can turn evidence into sustained business and clinical impact.

  4. Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial 8/20/2026

    Viral stock can make or break a norovirus challenge study. Cocrystal Pharma's Sam Lee explains why inoculum quality, infectivity, and availability matter.

  5. Everyone Is A Consultant Now 8/19/2026

    Jon Newton argues clinical research’s “vanishing middle” is giving rise to a more flexible workforce of consultants, specialists, and boutique firms.

  6. Rare Disease Study Gets A Boost From Crowdsourced Patient Reported Data 8/18/2026

    Jen A. Levitt, MD, explains how crowdsourced patient-reported data and AI tools can compress rare disease research timelines and surface new signals.

  7. What The Sponsor–CRO Relationship Gets Wrong — On Both Sides 8/17/2026

    The CRO's value is not execution alone. It is the depth of perspective that comes from having seen hundreds of trials across disease areas and regulatory environments. 

  8. The U.S. Clinical Trial Recruiting Pipeline Report – July 2026 8/17/2026

    This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from June through July 2026.

  9. The Art And Skill Of Caring For Terminally Ill Patients In Clinical Research And Beyond 8/14/2026

    When designing and conducting trials for terminally ill patients, Kamila Novak reminds researchers to act and speak with respect, warmth, and thoughtfulness.

  10. The Patient Advocacy Strategy Behind Skyhawk's Rapid Enrollment 8/13/2026

    Skyhawk’s patient-first approach shows how advocacy partnerships, site engagement, and operational quality can accelerate enrollment without losing focus on patients.